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The long terminal repeats of murine intracisternal A particles (IAPs) contain an IAP proximal enhancer
(IPE) element that is inactive in murine F9 embryonal carcinoma cells and active in the parietal endoderm cell
line PYS-2. The element binds efficiently to a 60-kDa IPE-binding protein (IPEB) present in PYS-2 cells but
poorly to F9 proteins, suggesting a role for IPEB in regulating IAP expression. We have purified calf thymus
IPEB, which binds to the IPE and transactivates a reporter gene in HeLa cell extracts. Based on the peptide
sequence of the purified calf IPEB, we have cloned a 420-bp cDNA and showed that the encoded protein is the
homolog of human p54nrb and mouse NonO, which are characterized by the presence of two RNA recognition
motifs. We show that p54nrb is an IPE-binding transcription activator with its DNA-binding and activation
domains in the N- and C-terminal halves, respectively. The activation domain of p54nrb is active in HeLa,
PYS-2, and F9 cells, whereas p54nrb as a whole molecule is active in HeLa and PYS-2 cells but not in F9 cells.
Thus, the lack of activity of p54nrb in F9 cells is due to an ineffective DNA-binding domain. We demonstrate that
p54nrb also binds to a pre-mRNA. Based on the close sequence relatedness of this protein to PSF, which is
required for pre-mRNA splicing in vitro, we discuss the possibility that p54nrb has dual roles in transcription
and splicing.
Murine intracisternal A particles (IAPs) are defective en-
dogenous retroviruses encoded by proviral elements that are
reiterated 2,000 times and dispersed throughout the genome.
IAPs are constitutively expressed at high levels in many mouse
tumors and at basal levels in most normal adult mouse tissues
(reviewed in references 21 and 22). In tumor cells where IAPs
are actively expressed, these elements transpose and act as
insertional mutagens via integration of actively synthesizing
extrachromosomal viral DNA to new sites in the host genome.
Such transpositions induce aberrant expression of target genes,
contributing to augmented growth autonomy of the host cell
and thus to the process of neoplastic transformation (21, 22,
25). Several germ line insertions contributing to mutagenesis
have also been found (7, 22). Thus, investigation of the mech-
anism of IAP transcriptional activation should ultimately lead
to an understanding of the role of endogenous retroviruses in
transposition-induced mutagenesis.
IAP proviral elements contain in their long terminal repeats
(LTRs) all of the cis-acting elements required for the enhance-
ment of IAP gene transcription (8, 23, 26). The cis elements
and their interacting transcription factors identified so far in-
clude the Enh1 and Enh2 elements located between nucleo-
tides (nt) 2164 and 2110, which bind to EBP-80 of murine
myeloma cells (13, 14), and sites located at the 59 end of the
LTR between nt 2210 and 2168, which bind to 28- and 46-
kDa proteins of murine PCC3 embryonal carcinoma (EC) cells
(40). In our analyses of the mechanism by which IAP expres-
sion becomes activated, we have found that IAP gene expres-
sion in murine F9 EC cells, which resemble early embryonic
cells, is restricted, whereas upon differentiation of these cells
into parietal endoderm-like cells, IAP expression becomes
highly activated. IAP expression is also activated in the parietal
endoderm cell line PYS-2 (18). Two DNA elements have been
identified. An IAP upstream enhancer element located be-
tween nt 2186 and 2167 is active in both F9 and PYS-2 cells
and binds to the 65-kDa zinc finger protein YY1 in a CpG
methylation-dependent manner, suggesting that IAP expres-
sion is regulated by site-specific methylation (32). We also
identified an IAP proximal enhancer (IPE) element that is
inactive in F9 cells and active in PYS-2 cells; the IPE binds
efficiently to a 60-kDa protein expressed in PYS-2 cells but
inefficiently to the corresponding protein in F9 cells (24). The
60-kDa IPE-binding protein (IPEB) is expressed in adult thy-
mocytes and activated splenic B cells (19), corresponding to
the pattern of IAP expression (27). These results suggest that
the IPE element and the 60-kDa IPEB play a role in regulating
the expression of the IAP gene.
In this present study, we have purified the 60-kDa IPEB
from calf thymus, cloned a cDNA fragment thereof, and shown
that this protein is the homolog of human p54nrb and mouse
NonO (10, 38). NonO is a recently isolated DNA-binding pro-
tein that recognizes an octamer motif in the immunoglobulin
heavy-chain promoter. NonO contains two RNA recognition
motifs (RRMs), each with two ribonucleoprotein (RNP) con-
sensus sequences (RNP1 and RNP2) known to bind to RNA
and single-stranded DNA (3, 4, 9, 33, 38). The NonO RRMs
bind to the single-stranded octamer motif, while a domain that
binds with low affinity to the double-stranded octamer motif
lies immediately downstream from the RRMs. Using cloned
p54nrb, we show that, like calf thymus and endogenous PYS-2
IPEB, p54nrb binds to the IPE, which has little similarity to the
octamer motif, and activates transcription from target genes.
We also demonstrate that p54nrb is a pre-mRNA-binding protein.
* Corresponding author. Mailing address: The Wistar Institute, 3601
Spruce St., Philadelphia, PA 19104. Phone: (215) 898-3796. Fax: (215)
898-3868.
† Present address: New York University Medical Center, New York,
N.Y.
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MATERIALS AND METHODS
Synthetic oligonucleotides. The sequences of oligonucleotides spanning nt
259 to 239 (IPE) of the IAP LTR (22) and containing the IPEB-binding site
(GAGTGAC) and mutations (mt2 to mt4) within the binding site are as follows:
IPE, GATCATCAGGGAGTGACACGTCCGA; IPE mt2, GATCATCAGGG
AAATTTACGTCCGA; IPE mt3, GATCATCAGTTTGTGACACGTCCGA;
IPE mt4, GATCATCAGGGAGTGTTGCGTCCGA; and CRE, GATCTTCCC
CGTGACGTCAACTCGGC. Mutated nucleotides are underlined. The CRE
oligonucleotide spanning nt 296 to 275 of the IAP LTR (23) contains the IPEB
recognition sequence (GTGAC). Only coding strands are shown.
Cell culture, preparation of nuclear and whole-cell extracts, and purification
of IPEB. Murine F9 and PYS-2 cell cultures and their nuclear and whole-cell
extracts, and whole-cell extracts from calf thymus, were prepared as described
previously (19). Purification of IPEB by sequence-specific DNA affinity chroma-
tography has been described elsewhere (19). Calf thymus proteins obtained after
two cycles of heparin-Sepharose (HS) column chromatography and two cycles of
DNA affinity chromatography were purified on preparative sodium dodecyl sul-
fate (SDS)-polyacrylamide gels as described previously (16), with modifications.
Briefly, proteins in the column eluate were resolved by SDS–10% polyacrylamide
FIG. 1. Partial purification of IPEB from F9 cells, PYS-2 cells, and calf
thymus. (A) Band shift assays. Equal amounts of total protein from whole-cell
extracts from calf thymus, PYS-2, and F9 cells were fractionated twice on an HS
column and twice on a DNA affinity column. Band shift assays were performed
with each chromatographic fraction, using the IPE sequence as a probe. To
identify the electrophoretic migration of the IPEB-IPE complex, PYS-2 nuclear
extracts were also used to bind to the IPE sequence (first lane from the left of
each panel). Results from the second chromatographic cycle are shown. Frac-
tions pooled for SDS-PAGE analysis shown in panel C are indicated. The
concentrations of KCl necessary to elute IPE-binding activity are indicated. (B)
SDS-PAGE of the calf thymus extract at different stages of purification. Thirty-
microgram aliquots of proteins in the eluates of the second cycle of HS and DNA
affinity chromatography were electrophoresed and visualized by Coomassie blue
staining. The arrow indicates the major 60-kDa protein. (C) SDS-PAGE of 30 mg
of twice-affinity-purified proteins from calf thymus, PYS-2, and F9 extracts.
Molecular masses are indicated in kilodaltons.
FIG. 2. Purification of IPEB by preparative SDS-PAGE. (A) SDS-PAGE of
DNA affinity-purified calf thymus IPEB. Proteins (150 mg) in the second-cycle
DNA column eluate were electrophoresed, and an end strip was cut from the
preparative gel and stained with Coomassie blue for visualization. The 60-kDa
IPEB and proteins of other sizes were isolated from the gel. (B) Analysis of 10
mg each of the isolated proteins. The arrow indicates the band representing BSA,
used to facilitate efficient precipitation and isolation of IPEB. (C) Band shift
analysis of the isolated proteins. About 50-ng aliquots of isolated proteins were
incubated without or with a 100-fold excess of the indicated competitors and
allowed to bind to 32P-labeled IPE. wt, the wild-type unlabeled IPE; mt 2, the
IPE mt2 oligonucleotide (see Materials and Methods for sequences).
TABLE 1. Purification of IPEB
Source Fraction Total protein(mg)
Total activitya
(U)
Sp act
(U/mg)
Purification
(fold)
Yield
(U)
PYS-2 Whole-cell extract 90 8,182 91 100
HS 2nd cycle 44 5,714 130 1.4 70
DNA affinity 2nd cycle 0.32 3,200 10,000 110 39
Calf thymus Whole-cell extract 4,200 232,044 55 100
HS 2nd cycle 306 102,000 333 6.1 44
DNA affinity 2nd cycle 6 54,545 9,090 165 24
SDS-PAGE (P60) 0.4 40,000 100,000 1,818 17
a One unit of activity is the amount of protein required to shift 1 fmol of probe out of 10 fmol in the presence of 1 mg of poly(dI-dC).
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gel electrophoresis (PAGE). A strip was cut from the gel, stained with Coomas-
sie blue, and used as a guide to isolate proteins in various regions of the gel.
Proteins were then precipitated at 2208C with acetone in the presence of 0.1 mg
of bovine serum albumin (BSA; molecular biology grade; Boehringer Mann-
heim) per ml. The precipitate was resuspended in 6 M guanidine to denature the
protein and then renatured by dialysis into band shift binding buffer containing
25 mM HEPES (pH 7.9), 60 mM KCl, and 5% glycerol.
Band shift assays and in vitro transcription. Band shift assays were carried out
as described previously (19). For in vitro transcription, template DNA was
prepared by PvuII digestion to generate runoff transcripts of 300 nt. Transcrip-
tion reactions were carried out in a volume of 25 ml containing 0.1 mg of template
DNA, 60 to 80 mg of nuclear extract, 10 mCi of [a-32P]UTP (3,000 Ci/mmol;
Amersham), 0.4 mM each ATP, CTP, and GTP, and 33 mg of poly(dI-dC) per ml
at 308C for 60 min in buffer containing 20 mM HEPES (pH 7.9), 100 mM KCl,
3 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol (DTT), and 20% glycerol.
Runoff transcripts were analyzed on a denaturing 6% polyacrylamide sequencing
gel.
Tryptic digestion of purified IPEBs, peptide sequencing, and RT-PCR. DNA
affinity column-purified calf thymus proteins were fractionated by SDS-PAGE,
transferred onto a polyvinylidene difluoride membrane (Bio-Rad), and visual-
ized by Coomassie blue staining. Proteins of 63, 60, 50, and 45 kDa were excised
and digested in situ with trypsin (1), and the resulting peptides were separated by
reverse-phase high-performance liquid chromatography (HPLC). Peptide se-
quencing (the Wistar Protein Microchemistry Facility) revealed six peptide se-
quences: NLEKQNHTPR, TFTQR, VELDNMPLR, CSEGSFLLTTFPR,
FAQPGSFEYEYAMR, and WK (sequences a to e). Peptides c and e were used
to synthesize degenerate primers. Since the relative order of the two tryptic
fragments within IPEB was not known, a combination of sense and antisense
degenerate oligonucleotides was used for reverse transcriptase-mediated PCR
(RT-PCR) using calf thymus total RNA as the template. Four prominent am-
plified fragments were detected from the primer pair containing the sense pep-
tide c and antisense peptide e. Hybridization with a probe containing the se-
quence 59 to the antisense peptide e primer identified a 420-bp fragment as the
correct RT-PCR product. This product was subcloned into pUC19 and se-
quenced.
Antibody production. Recombinant p54nrb was expressed in Escherichia coli as
described previously (10). Bacteria were resuspended and lysed by sonication in
20 mM HEPES-KOH (pH 8)–0.2 mM EDTA–20% glycerol–1 mM DTT–0.2
mM phenylmethylsulfonyl fluoride–6 M urea. The clarified extract was fraction-
ated by Mono Q chromatography in the same buffer. The flowthrough was
applied to a Mono S column, and bound material was eluted with a 0 to 1 M
NaCl gradient in the same buffer. Fractions containing pure p54nrb were pooled,
and urea was removed gradually by dialysis. Purified protein was used to immu-
nize BALB/c mice and to prepare monoclonal antibodies at the Cold Spring
Harbor Monoclonal Antibody Facility. A single specific anti-p54nrb immunoglob-
ulin M (IgM) monoclonal antibody was obtained.
Western blot analysis. Proteins were separated by SDS-PAGE and electro-
blotted onto nitrocellulose membranes (Micron Separations, Inc.). Immunoblot-
ting was performed as described previously (2), using a monoclonal antibody
(IgM) to p54nrb and goat anti-mouse immunoglobulins (IgG, IgM, and IgA)
conjugated to alkaline phosphatase (Cappel) as the second antibody.
In vitro transcription and translation of p54nrb and binding of the encoded
protein to the IPE sequence. Full-length and N- and C-terminal halves of p54nrb
were subcloned into pBluescript (Stratagene) and transcribed with T3 polymer-
ase (Promega). Subcloning of N and C termini was accomplished by PCR with
primers that incorporated an in-frame termination codon and a Kozak sequence
surrounding an in-frame ATG initiation codon, respectively. The resulting tem-
plates were transcribed and capped by using a kit (Stratagene) according to the
manufacturer’s specifications, and plasmid DNA was digested with RNase-free
DNase (Boehringer Mannheim). The capped mRNA was then translated in vitro
in a rabbit reticulocyte lysate (Promega) in the presence or absence of [35S]me-
thionine. As a control, a luciferase cDNA in pBluescript was transcribed and
translated. The translated nonradioactive products were used in band shift as-
FIG. 3. DNA-binding specificity of the purified 60-kDa calf thymus IPEB. (A) Competition experiments. The SDS-PAGE-purified calf thymus IPEB and, as
controls, the partially purified PYS-2 IPEB after the second cycle of the DNA affinity chromatography and the unpurified IPEB in PYS-2 nuclear extracts were
incubated without or with a 100-fold excess of the indicated competitors and then with the IPE probe. The resulting complexes were analyzed by band shift assays. wt,
the wild-type unlabeled IPE sequence; mt2, mt3, and mt4, IPE mutant oligonucleotides (see Materials and Methods for sequences). (B) Band shift assays with the CRE
sequence. The purified calf thymus IPEB was incubated with probe IPE, CRE, or IPE mt2, and the complexes were analyzed. The amounts of IPEB used in the binding
reactions are indicated above the lanes. The arrow shows the migration position of the IPEB-IPE complex.
FIG. 4. IPEB stimulates in vitro transcription from an IPE promoter. (A)
Templates for in vitro transcription reactions. IPE TK-CAT and IPE mt2 TK-
CAT contain five copies of wild-type and mutated IPEB binding site, respec-
tively, inserted in front of a TK-CAT reporter. PvuII sites were used to linearize
the templates, and the expected runoff transcript is 300 bases. (B) In vitro
transcription assays. Template DNA (100 ng) was transcribed in vitro in PYS-2,
F9, or HeLa extracts in the presence (1) or absence (2) of 300 ng of purified
60-kDa calf thymus IPEB unless indicated otherwise. 277/249 TK-CAT con-
tains three copies of a sequence located between nt 277 and 249 in the IAP
LTR (21).
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says. The radioactive proteins were bound to a DNA affinity column as described
previously (19). The bound proteins, and as a control the unpurified total trans-
lated products, were precipitated with acetone in the presence of BSA, separated
by SDS-PAGE, and visualized by autoradiography.
Systematic evolution of ligands by exponential enrichment (SELEX). An
RNA library of 68-mers containing a central 25-nt degenerate region was
prepared as previously described (36). Five nanomoles of initial RNA pool
was incubated with 50 pmol of purified recombinant p54nrb at 308C for 30 min
in 200 ml of buffer containing 20 mM HEPES (pH 7.3), 3.2 mM MgCl2, 60
mM KCl, and 0.5 mM DTT and filtered through a nitrocellulose disc prewet-
ted with the same buffer. The disc was washed twice in the same buffer and
extracted with a mixture containing 400 ml of phenol (pH 6.3) and 200 ml of
7 M urea in an Eppendorf tube with agitation for 30 min at room tempera-
ture. After addition of 200 ml of H2O and vortexing, the sample was centri-
fuged for 10 min at 48C, and RNA was recovered from the aqueous phase by
ethanol precipitation. Further steps of amplification and selection (total of five
rounds) and final subcloning and sequencing were performed as described pre-
viously (36).
UV cross-linking. Human b-globin pre-mRNA or mRNA comprising the first
exon and most of the second exon (with or without the first intron) was prepared
by in vitro transcription with SP6 RNA polymerase, using BamHI-linearized
plasmids SP64-HbD6 and SP64-HbD6-IVS1,2 (20) in the presence of
[a-32P]ATP, -GTP, -CTP, and -UTP. Twenty femtomoles of uniformly labeled
RNA was incubated with 0, 3, 9, or 27 pmol of purified recombinant p54nrb
expressed in E. coli, in 15 ml of splicing buffer (20 mM HEPES-NaOH [pH 8],
100 mM KCl, 5% glycerol, 0.2 mM EDTA, 0.5 mM DTT) containing 50 ng of
RNase-free BSA per ml, for 20 min at 308C. The mixture was UV irradiated
twice at 900 mJ/cm2 in a Spectrolinker XL-100 UV crosslinker (Spectronics Co.),
treated with 1.6 mg of RNase A at 378C for 20 min, boiled for 3 min in SDS
sample buffer, and loaded on an SDS–12% polyacrylamide gel. The gel was
stained with Coomassie blue to locate the markers, dried, and analyzed by
autoradiography.
Transfection assays. Cells were cotransfected with 4 mg of reporter plasmid, 3
mg of expression plasmid, and 5 mg of pRSV-LacZ (as an internal control for
transfection efficiency) by the calcium phosphate precipitation method as de-
scribed previously (32). The total amount of transfected DNA was adjusted to 12
mg with pUC18. The reporter plasmids, TK-CAT (pBLCAT2), (GAL4)5-TK-
CAT, and PYF TK-CAT, have been described elsewhere (32). IPE TK-CAT and
IPE mt2 TK-CAT contain five copies of IPE and IPE mt2 inserted in front of
TK-CAT, respectively. The expression plasmid pSV2-p54nrb contains a full-
length p54nrb cDNA subcloned in the expression vector pECE, which contains
the simian virus 40 early promoter and enhancer (11). pSV2GAL4(1-147) is the
previously described pSG424 (32). pSV2GAL4(1-147)/N-term, pSV2GAL4(1-
147)/C-term, and pSV2GAL4(1-147)/reverse C-term contain the N terminus, C
terminus, or antisense C terminus of p54nrb, respectively, inserted in frame in
pSG424. Chloramphenicol acetyltransferase (CAT) assays were performed as
described previously (23).
RESULTS
Purification of IPEB from calf thymus. We showed previ-
ously that among the mouse tissues examined, IPEB activity is
most abundant in thymus and that this activity is conserved in
various species, including calf (19). Thus, whole-cell extracts
from calf thymus were used to obtain a large quantity of IPEB
through two cycles of HS and two cycles of DNA affinity
column chromatography. As controls, PYS-2 and F9 cell ex-
tracts were also fractionated. The IPE-binding activity of each
chromatographic fraction was monitored by band shift assays.
The IPE-binding activity in calf thymus extracts and in control
PYS-2 and F9 extracts eluted between 0.25 and 0.55 M KCl in
the first (not shown) and second cycles of HS chromatography,
with respective peak fractions at 0.39, 0.4, and 0.41 M KCl (Fig.
1A). In a DNA affinity column, calf IPEB eluted between 0.32
FIG. 5. Identification of calf thymus IPEB. (A) Reverse-phase HPLC of tryptic peptides from the SDS-PAGE-purified 63-, 60-, 50-, and 46-kDa calf thymus
proteins. Absorbance profiles within retention times of 25 to 78 min are shown. The full scale of each chromatogram corresponds to 0.05 (0.02 to 0.07) absorbance unit
at 215 nm. (B) Schematic comparison of murine NonO, human p54nrb, and the RT-PCR product amplified from calf thymus RNA. RNP1 and RNP2, RNP consensus
sequences; UTR, untranslated region. The locations of peptide sequences a to f (see Materials and Methods) identified in the SDS-PAGE-purified calf thymus IPEB
are shown above the NonO sequence. Numbers below NonO and p54nrb sequences represent amino acid positions of the respective proteins (10, 38). Numbers in the
RT-PCR product from calf thymus are based on the p54nrb sequence.
FIG. 6. Western blot analysis. p54nrb synthesized in bacteria (Bact), SDS-
PAGE-purified calf IPEB (C. Thy), twice-DNA-affinity-purified PYS-2 IPEB
(PYS-2), and nuclear extracts from PYS-2, HeLa, and F9 cells were fractionated
on an SDS–10% polyacrylamide gel and transferred to nitrocellulose for Western
blotting. The filters were probed with a monoclonal antibody raised against
human p54nrb expressed in E. coli.
680 BASU ET AL. MOL. CELL. BIOL.
 o
n
 M
arch 11, 2014 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
to 0.7 M KCl, with the peak fraction at 0.52 M KCl, while
PYS-2 IPEB eluted between 0.4 and 0.6 M KCl, peaking at
0.49 M, and F9 IPEB eluted between 0.27 and 0.44 M KCl,
with a peak fraction at 0.35 M. The fact that calf IPEB and
PYS-2 IPEB elution peaked around similar salt concentrations
(0.52 and 0.49 M, respectively), while F9 IPEB elution peaked
at a much lower salt concentration (around 0.35 M KCl),
suggests that DNA-binding affinities of calf thymus and PYS-2
IPEB are similar and both differ from that of F9 IPEB. Table
1 summarizes the purification of IPEB. Major purification oc-
curred with the DNA affinity chromatography, resulting in 110-
and 165-fold enrichment over levels for the initial PYS-2 and
calf thymus extracts, respectively. SDS-PAGE analysis of
IPEB-containing calf thymus fractions at each step of purifi-
cation further revealed that a 60-kDa protein was enriched as
the most prominent protein in the DNA affinity eluate (Fig.
1B). Consistent with previous findings (23), SDS-PAGE anal-
ysis of equal amounts of twice-affinity-purified proteins also
revealed that the 60-kDa IPEB-binding activity is abundant in
PYS-2 but not in F9 cells (Fig. 1C).
The affinity-purified calf thymus proteins were further puri-
fied by preparative SDS-PAGE (Fig. 2A). Individual proteins
were isolated from the gel and reanalyzed by SDS-PAGE (Fig.
2B). Band shift analysis of the renatured proteins (Fig. 2C)
showed that the 60-kDa protein and the less abundant 63-, 50-,
and 45-kDa proteins independently bound to the IPE se-
quence. Among these proteins, binding of the 63-kDa species
was the weakest. Competitive binding experiments indicated
that the unlabeled IPE sequence competed efficiently with the
labeled IPE probe for binding to the 60-kDa protein but less
efficiently with the probe for binding to the 50- and 45-kDa
proteins. The mt2 oligonucleotide, which contains a mutation
within the IPE sequence, failed to compete for binding to all
three proteins. Thus, the 60-kDa calf thymus protein contains
the IPEB activity. Hereafter, the 60-kDa calf thymus protein is
referred to as the calf thymus IPEB. The significance of the 50-
and 45-kDa proteins will be discussed below.
The DNA-binding specificity of the purified calf thymus
IPEB was then compared to that of endogenous PYS-2 IPEB
in nuclear extracts. In band shift assays, the purified calf thy-
mus IPEB and the DNA affinity-purified PYS-2 IPEB bound to
the IPE probe and yielded complexes with electrophoretic
mobilities identical to that of the complex produced from the
binding of the unfractionated PYS-2 IPEB in nuclear extracts
to the IPE probe (Fig. 3A). The three complexes showed identical
competition patterns with unlabeled IPE oligonucleotide and
with mutant oligonucleotides. The unlabeled IPE sequence com-
peted efficiently with the probe for IPEB binding. IPE mt2, which
contains a 5-bp mutation within the IPE element, and IPE mt4,
which has a 3-bp mutation toward the 39 end of the binding
site, failed to compete for IPEB binding. IPE mt3, which has a
3-bp mutation toward the 59 end of the binding site, competed
efficiently for IPEB binding. The results further support the
conclusion that the 60-kDa calf thymus protein is an IPEB and
that the major recognition site is GTGAC located between nt
251 to 247, refined from GAGTGAC identified previously by
methylation interference assays (24).
FIG. 7. Binding of p54nrb to IPE. (A) DNA affinity chromatography. p54nrb
and control luciferase template DNAs were transcribed and translated in vitro
and bound to resin containing either the IPE or IPE mt2 oligonucleotide in the
presence of poly(dI-dC). The resin was washed, and bound protein was eluted
with 1 M KCl and analyzed by SDS-PAGE. A 60-kDa protein encoded by p54nrb
bound efficiently to the IPE but not the IPE mt2 oligonucleotide. (B) Band shift
assays with in vitro-translated p54nrb. p54nrb transcribed and translated in vitro in
the forward (sense) orientation was incubated with the IPE probe in the presence
or absence of a 50-fold excess of the indicated competitors. As controls, proteins
were transcribed and translated from p54nrb cDNA in the reverse (antisense)
orientation, luciferase cDNA, or pBluescript vector or in the absence of template
DNA (reticulocyte lysate alone). The faint bands in the control lanes represent
complexes derived from the endogenous p54nrb present in reticulocyte lysates.
(C) Band shift assay with recombinant p54nrb. p54nrb synthesized in bacteria
(bact.) was incubated with the IPE probe. No complex comigrating with the
IPE-calf thymus IPEB complex is visible.
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Since the CRE oligonucleotide contains the IPEB-binding-
site sequence GTGAC (see Materials and Methods for the
sequence), the ability of the calf thymus IPEB to bind to the
CRE oligonucleotide was tested (Fig. 3B). Band shift assays
indicated poor binding of the protein to the CRE, while the
same amount of IPEB was able to bind the IPE sequence and
to form a IPEB-IPE complex in a sequence-specific manner,
being unable to bind to the IPE mt2 sequence. Thus, in addi-
tion to the binding site sequence, the flanking sequence influ-
ences IPEB-binding activity. This conclusion is consistent with
our observation that a PYS-2 nuclear protein-IPE sequence
complex migrates differently than a CRE sequence complex of
the same nuclear protein (our unpublished results).
Transcriptional activity of the purified 60-kDa IPEB. To
further confirm the identity of the purified calf IPEB, we an-
alyzed the transcriptional potential of the protein. In vitro
runoff transcription experiments were performed with nuclear
extracts derived from F9, PYS-2, and HeLa cells and, as a
template, an IPE TK-CAT reporter plasmid containing five
copies of the oligonucleotide encompassing the IPE (Fig. 4). In
the absence of exogenous IPEB, the endogenous IPEB in the
HeLa extract directed transcription from the IPE TK-CAT
plasmid at 2.6 times the activity of TK-CAT. Addition of pu-
rified IPEB to the in vitro transcription mixture resulted in an
additional increase in transcription in a dose-dependent man-
ner, 1.5-fold at 150 ng and 2.2-fold at 300 ng. This transcrip-
tional activation by endogenous or endogenous plus exogenous
IPEB was abolished when the IPE was mutated (IPE mt2).
Thus, purified IPEB acts as a sequence-specific transcriptional
activator. The transcription by HeLa extracts was sensitive to
a-amanitin (1 mg/ml) (not shown), indicating that transcription
is mediated by RNA polymerase II.
As expected from previous studies (24), the endogenous
IPEB in PYS-2 extracts led to efficient transcription of the IPE
TK-CAT reporter gene (Fig. 4). Addition of purified IPEB did
not result in any measurable increase in transcription, possibly
due to the abundance of the endogenous factor. The F9 ex-
tract, on the other hand, failed to give a measurable increase in
transcription from the IPE TK-CAT plasmid above the level
obtained with TK-CAT, either in the presence or in the ab-
sence of exogenous IPEB. The possibility that such failure was
due to poor extract preparations was ruled out since the F9
extract was shown to direct active transcription from a plasmid
containing a different DNA element located between nt 277
and 249 of the IAP LTR (Fig. 4). In a mixing experiment,
addition of F9 extracts to PYS-2 extracts abolished the ability
of the latter to activate transcription, suggesting that the pu-
tative F9 inhibitor is dominant (results not shown).
Tryptic maps of 63-, 60-, 50-, and 45-kDa IPEBs. The rela-
tionship between the 60-kDa IPEB and other IPEBs was in-
vestigated by tryptic mapping (Fig. 5A). The 60-, 50-, and
45-kDa proteins, which bind efficiently to the IPE sequence,
gave nearly identical tryptic maps, whereas the 63-kDa protein,
which binds weakly to the IPE sequence, gave a different pro-
file. Thus, the 60-, 50-, and 45-kDa proteins are closely related,
while the 63-kDa protein is likely an unrelated protein. Among
six peptide sequences (a to f; Fig. 5B) isolated from the 60-kDa
protein and analyzed, sequence a is present in the 45-kDa
protein while sequence d is present in the 50-kDa protein,
indicating that the three proteins may represent posttransla-
tionally modified or differentially spliced products or proteo-
lytic products.
Identification of IPEB as NonO/p54nrb. Two peptide se-
quences (c and C-terminal half of e; Fig. 5B) from the 60-kDa
calf thymus IPEB were used to prepare degenerate oligonu-
cleotide primers for RT-PCR using calf thymus RNA as the
template. A 420-bp amplified cDNA gave positive hybridiza-
tion to a probe containing a nucleotide sequence correspond-
ing to the N-terminal half of peptide e; this cDNA was sub-
cloned into pUC19 and sequenced. Searches of DNA
databases revealed that the amplified cDNA has complete
sequence homology to NonO (97.2% at the nucleotide level
and 97% at the amino acid level) cloned from BCL1 cells (38)
and to its human homolog p54nrb (98.4% at the nucleotide
level and 98.6% at the amino acid level) cloned from HeLa
cells (10). Furthermore, all of the peptide sequences identified
in the purified 60-kDa calf IPEB are present in NonO/p54nrb
(Fig. 5B). Thus, IPEB is very likely the homolog of NonO/
p54nrb.
A monoclonal antibody to p54nrb recognizes IPEB. Western
analysis (Fig. 6) showed that a monoclonal antibody to p54nrb
synthesized in bacteria reacted not only with the recombinant
p54nrb protein, as expected, but also with the SDS-PAGE-
purified calf thymus IPEB and the DNA affinity-purified
PYS-2 IPEB. All three proteins have an apparent molecular
mass of 60 kDa. Analysis of nuclear extracts revealed the
presence of antibody-reactive 60-kDa proteins not only in
PYS-2 and HeLa cells, where the endogenous 60-kDa IPEB is
functionally active as indicated by the in vitro transcription
assays, but also in F9 extracts, where the 60-kDa IPEB is
functionally inactive. Thus, IPEB is present in F9 cells.
p54nrb is a sequence-specific DNA-binding protein that rec-
ognizes the IPE. The in vitro-transcribed and -translated
p54nrb, like the purified calf thymus IPEB, bound efficiently to
DNA affinity resin containing the IPE but not to that contain-
FIG. 8. Characterization of the DNA-binding domain of p54nrb. (A) Sche-
matic representation of N- and C-terminal p54nrb translated from reticulocyte
lysates. Abbreviations are as in Fig. 5B. (B) Band shift analysis. N and C termini
of p54nrb synthesized with reticulocyte lysates in the forward (sense) and reverse
(antisense) orientations were incubated with the IPE probe in the presence or
absence of a 50-fold excess of competitors, the IPE and IPE mt2 oligonucleo-
tides. As controls, reticulocyte lysate and calf thymus IPEB were also used in
band shift assays.
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ing IPE mt2 (compare Fig. 7A with Fig. 3A). The control in
vitro-translated luciferase did not bind to the DNA affinity
column containing IPE. In band shift assays (Fig. 7B), p54nrb
synthesized in the forward (sense) orientation in reticulocyte
lysate also bound to the IPE and produced a DNA-protein
complex comigrating with the complex produced from the
binding of the IPE to the purified calf thymus IPEB (Fig. 7B,
lanes 1 and 2). Moreover, the two complexes, IPE-p54nrb and
IPE-calf thymus IPEB, showed identical competition patterns;
the unlabeled IPE was an efficient competitor, while IPE mt2
was not (compare Fig. 7B with Fig. 3A). Thus, p54nrb has the
same binding specificity as the calf thymus IPEB. As controls,
we also translated p54nrb in reverse (antisense) orientation,
luciferase, and proteins from empty vector pBluescript in re-
ticulocyte lysates. The translated proteins from all of these
controls formed a faint complex band comigrating with the
IPE-p54nrb complex (Fig. 7B; compare lanes 5 to 7 with lane 2).
Incubation of the reticulocyte lysate with the IPE probe also
yielded the same faint comigrating complex band (lane 8),
suggesting the presence of endogenous p54nrb or a related
protein in the reticulocyte lysate. Thus, the faint complex
bands produced in control lanes likely represent those derived
from the endogenous p54nrb present in the reticulocyte lysates.
The protein synthesized in bacteria failed to bind to the IPE
(Fig. 7C). This is unlikely to be the result of incorrect folding,
since the same protein is capable of binding RNA (see below).
The failure to bind DNA suggests that posttranslational mod-
ification is required for efficient DNA binding.
Localization of the DNA-binding domain of p54nrb. The N-
terminal half of p54nrb comprises two canonical RRMs (10).
The same region of the mouse homolog, NonO, binds to sin-
gle-stranded DNA and RNA (36). We thus generated N- and
C-terminal peptides by in vitro transcription of subclones con-
taining appropriate domains of p54nrb and used the translated
peptides for band shift assays (Fig. 8B). The N-terminal pep-
tide translated in the forward (sense) orientation bound to the
IPE probe (lane 1). Interestingly, even though the N-terminal
peptide is half the size of the full-length p54nrb (calf thymus
IPEB), the two complexes had essentially identical electro-
phoretic mobilities (compare lanes 1 and 8). The control N-
terminal peptide translated in the reverse (antisense) orienta-
tion yielded a faint comigrating complex band (lane 4). The
C-terminal peptide synthesized in the forward or reverse ori-
entation or the reticulocyte lysate alone also produced a faint
comigrating complex (lanes 5 to 7). Thus, as in Fig. 7B, the
faint complex bands (Fig. 8B, lanes 2 and 4 to 7) likely repre-
sent complexes derived from the endogenous p54nrb present in
the reticulocyte lysate.
p54nrb transactivates target genes in vivo. To further test the
function of p54nrb as an IPEB, we analyzed its ability to activate
transcription from the IPE sequence by cotransfection assays
(Fig. 9). Expression plasmid pSV2-p54nrb was cotransfected
with the reporter plasmid IPE TK-CAT into HeLa, PYS-2, and
F9 cells. In HeLa cells, the endogenous IPEB itself mediated
an approximately sixfold increase in CAT activity. Cotransfec-
tion of pSV2-p54nrb resulted in an additional sixfold increase in
the levels of CAT activity. The ability of p54nrb expressed from
pSV2-p54nrb to activate transcription is IPE sequence specific,
since mutation within the IPE abolished the ability of p54nrb to
stimulate CAT activity. The possibility that p54nrb, being an
RNA-binding protein, stabilizes the reporter mRNA and thus
increases the steady-state CAT mRNA levels was ruled out,
since the PYF TK-CAT reporter, which contains a mutant
polyomavirus enhancer, failed to respond to cotransfected
p54nrb. In PYS-2 cells, the endogenous IPEB stimulated CAT
activity 120-fold, and cotransfection with the expression plas-
mid resulted in a slight decrease in CAT activity, suggesting the
presence of a titratable cellular factor that interacts with IPEB.
FIG. 9. Transcriptional activity of p54nrb in vivo. PYS-2, F9, and HeLa cells were transfected with the reporter gene IPE TK-CAT and, as controls, with TK-CAT
and IPE mt2 TK-CAT in the absence (2) or presence (1) of the p54nrb expression plasmid, pSV2-p54nrb. The upper panel shows the autoradiograms of products from
CAT assays. The lower panel illustrates the CAT activity relative to TK-CAT activity, set at 1. Results are the averages of six independent transfections, and the standard
deviation did not exceed 2.7. Cotransfection with empty expression vector pECE gave only basal activity (results not shown). PYF TK-CAT has been described
elsewhere (21).
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The endogenous IPEB in F9 cells, on the other hand, did not
stimulate any CAT activity, nor did cotransfection with the
expression plasmid, suggesting that the transactivation activity
of p54nrb is inhibited in F9 cells.
To further confirm that p54nrb is a transcription activator,
the N-terminal (amino acids 1 to 228) and C-terminal (amino
acids 228 to 471) halves of p54nrb were expressed as fusion
proteins with the GAL4 DNA-binding domain [GAL4(1-147)].
The plasmids expressing the fusion proteins were cotransfected
with a TK-CAT reporter plasmid containing a GAL4 DNA-
binding site into HeLa, PYS-2, and F9 cells (Fig. 10). In all three
cell types, the C-terminus fusion protein enhanced transcription
but the N-terminus fusion protein did not. Control experiments
showed that the C-terminus activity was not due to the effect of
the GAL4 DNA-binding domain, since the empty vector pSV2
GAL4(1-147) or the antisense C-terminus plasmid pSV2
GAL4(1-147)/reverse C-term produced only a basal level of re-
porter gene expression. Since the C-terminus fusion protein was
an effective transactivator in F9 cells, whereas the full length
protein was not (Fig. 9), we conclude that the DNA-binding
domain, but not the activation domain, is defective in F9 cells.
p54nrb is an RNA-binding protein. To determine if recom-
binant p54nrb can bind RNA, the purified protein was incu-
bated with radiolabeled pre-mRNA of 497 or 367 nt containing
the first two exons of human b-globin with or without the first
intron. Exposure to UV light resulted in cross-linking of p54nrb
to both RNAs, as determined by RNase A treatment followed
by SDS-PAGE and autoradiography (Fig. 11). To determine if
p54nrb binds to a specific RNA sequence, a SELEX experiment
was performed (Fig. 12). After five rounds of selection, p54nrb
preferentially bound short RNAs that were G rich and con-
tained one or more copies of the consensus element
AGGGA/U. We verified in filter binding experiments that the
purified recombinant p54nrb bound with higher affinity to short
RNAs containing the SELEX motif than to control short
RNAs lacking the motif, including a b-globin intron fragment
(data not shown). Thus, the observed binding of p54nrb to the
b-globin RNAs that lack the SELEX motif (Fig. 11) is likely to
be characterized by low affinity as well.
DISCUSSION
We showed previously that the transcriptional activity of a
60-kDa IPEB and its recognition motif IPE in the IAP LTR is
high in PYS-2 cells but very low in F9 cells, suggesting that
IPEB activity plays a role in active versus restricted expression
of IAP in the corresponding cells (24). In the present study, we
FIG. 10. Characterization of the transcriptional activation domain of p54nrb.
HeLa, PYS-2, and F9 cells were cotransfected with reporter genes and plasmids
expressing fusion proteins containing GAL4(1-147) and the N or C terminus of
p54nrb, as indicated. The relative CAT activities were calculated against the basal
reporter plasmid TK-CAT and then against the reporter plasmid (GAL4)5-TK-
CAT [containing five copies of GAL4(1-147)] to illustrate transcriptional en-
hancement by cotransfected expression plasmids.
FIG. 11. p54nrb binds RNA. Binding of purified, recombinant p54nrb to b-glo-
bin RNA was assayed by UV cross-linking. Twenty femtomoles of in vitro-
transcribed, uniformly labeled b-globin pre-mRNA or mRNA was incubated
with the indicated amounts (picomoles) of recombinant p54nrb, in buffer con-
taining BSA, at 308C for 20 min, UV irradiated, and digested with RNase A as
described in Materials and Methods. The products were analyzed by SDS-PAGE
and autoradiography. The positions of molecular weight markers are indicated in
kilodaltons (note that the cross-linked RNA fragments result in slower mobility
of p54nrb).
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purified a 60-kDa IPEB from calf thymus that behaved simi-
larly to the mouse PYS-2 IPEB activity; i.e., it bound to the
IPE and transactivated a reporter gene from the binding site in
HeLa nuclear extracts. We also cloned a 420-bp cDNA by
RT-PCR using partial amino acid sequence from the calf
IPEB. The sequence of the product of this cDNA was highly
homologous to those of the previously cloned human p54nrb
(10) and mouse NonO (38). In addition, all of the peptide
sequences identified in the purified calf thymus IPEB were
present within the p54nrb and NonO sequences. Western anal-
ysis showed that a monoclonal antibody to the human p54nrb
reacted with the calf IPEB and PYS-2 IPEB and that the calf
and PYS-2 IPEBs and p54nrb had identical relative electro-
phoretic mobilities of 60 kDa. In vitro-transcribed and -trans-
lated p54nrb bound to the IPE sequence, and p54nrb expressed
in HeLa cells transactivated a CAT reporter gene in an IPE-
dependent manner. Furthermore, we localized the IPE-bind-
ing and transactivation domains of p54nrb to the N and C
termini, respectively. Thus, based on its sequence homology,
molecular size, antibody cross-reactivity, DNA-binding speci-
ficity, and transcriptional activity, we established that p54nrb/
NonO is, like calf or PYS-2 IPEB, an IPE-binding transcription
activator.
Although p54nrb in HeLa cells functions as a transcription
activator in vitro and in vivo, it did not do so in PYS-2 cells. In
fact, endogenous p54nrb activity was slightly reduced in cotrans-
fection assays, suggesting the presence of a titratable factor in
PYS-2 cells that interacts with p54nrb. In F9 cells, p54nrb failed
to activate transcription in vitro and in vivo. Results from
several experiments suggest that the transcriptional inactivity
of p54nrb in F9 cells is due to its inability to bind IPE. First, we
showed by Western analysis that p54nrb is present in F9 cells.
Second, we showed by DNA affinity chromatography that F9
IPEB bound poorly to IPE, confirming our previous South-
western data (23). Third, the GAL4(1–147)/C-terminus fusion
protein was an effective transcription activator in F9 cells.
Furthermore, we predict that the inability of F9 IPEB to bind
IPE is due to absent or incomplete posttranslational modifi-
cation, in view of the fact that the recombinant p54nrb ex-
pressed in bacteria failed to bind IPE whereas p54nrb translated
in reticulocyte lysate, which contains mammalian kinases and
other modification activities, bound to the IPE effectively.
In addition to being a transcription factor, p54nrb, which
contains two adjacent, canonical RRMs in its N terminus, is a
single-stranded RNA-binding protein. We have shown here
that recombinant p54nrb binds with high affinity to short G-rich
($50%) RNAs that contain one or more copies of the motif
AGGGA/U compared to control RNAs of the same length
that lack the motif. In the absence of other proteins, p54nrb can
bind to longer RNAs that lack precise copies of the motif,
probably through a cooperative binding mode. For example,
we showed binding of recombinant p54nrb to b-globin pre-
mRNA and mRNA, and previous work showed binding to the
chicken b-tropomyosin first intron and to single-stranded ribo-
homopolymers, particularly poly(G) and poly(U) (17). Simi-
larly, the splicing factor hnRNP A1, which also has two RRMs,
binds cooperatively to most, if not all, cellular transcripts but
has much higher affinity for short RNAs with the hexanucle-
otide motif UAGGGA/U (5), which, interestingly, comprises
the pentanucleotide SELEX consensus for p54nrb. Moreover,
the oligonucleotides AGGGA, GGGU, GGGA, AGGG, and
GGG are present at higher than expected frequencies in ver-
tebrate introns (12, 28). In addition, p54nrb appears to be a
splicing factor. An affinity depletion experiment showed that
depletion of p54nrb inhibited splicing of b-globin in vitro (17).
Mutational analysis revealed that the SELEX motif
AGGGA/U is part of an intronic enhancer required for effi-
cient splicing of chicken b-tropomyosin intron B7, which is
known to cross-link to an unidentified protein very similar in
size to p54nrb (34). Thus, p54nrb appears to be a splicing factor
with limited but detectable nucleotide sequence and/or com-
position-based RNA-binding preferences. The same p54nrb do-
main may be used for RNA and DNA binding; NonO was
shown to bind RNA from the N terminus (38), while we
showed that the same domain in p54nrb binds to the IPE.
Interestingly, however, the putative posttranslational modifi-
cation appears to be required for DNA binding but not for
RNA binding. This observation raises the interesting possibil-
ity that posttranslational modification serves to switch between
RNA- and DNA-binding modes of the protein.
Besides having pre-mRNA-binding properties, p54nrb has
striking sequence similarity to the splicing factor PSF (10),
which has been shown to be required for catalytic step II of
splicing of an a-tropomyosin pre-mRNA in vitro (15). Human
p54nrb (471 amino acids) and human PSF (712 amino acids) are
70% identical in an internal ungapped region of 320 amino
acids, the N-terminal half of which comprises both RRMs (10).
In addition, p54nrb and PSF are basic, and both proteins have
proline- and glutamine-rich N termini (10, 30, 38) which are
present not only in many transcription factors but also in many
RNA-binding proteins (reference 30 and references therein).
Thus, Patton et al. (30) hypothesized that the glutamine/pro-
line- and proline-rich regions are binding sites for recognition
and assembly of additional factors during the formation of
transcription complexes and spliceosomes.
Given the extensive similarity between PSF and p54nrb, it
would be surprising if these two factors functioned in entirely
different nuclear processes. Transcription and splicing are usu-
FIG. 12. Alignment of RNA sequences selected by p54nrb. Five rounds of SELEX were carried out with an RNA library of 68-mers with 25 nt of degeneracy in the
center and purified recombinant p54nrb. RNA-protein complexes were selected at each cycle by binding to nitrocellulose filters, and the enriched RNAs were amplified
by RT-PCR. Thirty cDNA clones, representing eight different sequences, were sequenced after round 5. Seven of the eight sequences share the pentanucleotide
consensus element AGGGA/U, which occurs twice in two of the sequences (for which both alignments are shown). Additional partial matches also occur in several
of the sequences but are not shown for simplicity. The same seven sequences also have a high G content (.50%), as indicated on the right.
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ally coupled in vivo, since many, though not all, introns are pro-
cessed as part of nascent transcripts (reviewed in reference 35).
An additional link between these two nuclear processes has been
previously suggested, based on the observation that when in vivo
splicing is reversibly inhibited by microinjection of oligonucleo-
tides or antibodies that inhibit splicing, transcriptional activity is
correspondingly reduced (29). Furthermore, the Drosophila B52
splicing factor was shown to cross-link in vivo to DNA that flanks
the transcribed regions of the fully activated heat shock genes (6),
suggesting association of B52 with the promoter. An ETS-
related transcription factor, SPI-1/Pu.1, was recently shown to
bind RNA, competing with p54nrb binding, and to interfere
with pre-mRNA splicing in vitro (13). Moreover, SPI-1/Pu.1
and p54nrb appear to associate in vivo. Thus, transcription and
RNA processing appear to be intimately connected nuclear
processes that may share common factors (35, 37, 39). It will be
of interest to determine the association of p54nrb with pro-
moter elements and transcribed regions of specific genes in
vivo, which should further define its roles in nuclear processes.
ACKNOWLEDGMENTS
We thank G. Prendergast for critical reading of the manuscript, and
we thank L. Showe and F. Rauscher III for helpful discussion.
This work was supported by Public Health Service grants GM37762
and GM47421 from the National Institute of General Medical Sci-
ences (C.C.H.), by grants CA10815 from the National Cancer Institute
and BIR-9318027 (to The Wistar Institute), and by grant CA13106
from the National Cancer Institute (A.R.K.).
REFERENCES
1. Aebersold, R. H., J. Leavitt, R. A. Saavedra, L. E. Hood, and S. B. H. Kent.
1987. Internal amino acid sequence analysis of proteins separated by one- or
two-dimensional gel electrophoresis after in situ protease digestion on ni-
trocellulose. Proc. Natl. Acad. Sci. USA 84:6970–6974.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A.
Smith, and K. Struhl (ed.). 1990. Current protocols in molecular biology, p.
10.81–10.86. Green Publishing Associates and Wiley Interscience, John
Wiley and Sons, New York, N.Y.
3. Birney, E., S. Kumar, and A. R. Krainer. 1993. Analysis of the RNA-
recognition motif and RS and RGG domains: conservation in metazoan
pre-mRNA splicing factors. Nucleic Acids Res. 21:5803–5816.
4. Burd, C. G., and G. Dreyfuss. 1994. Conserved structures and diversity of
functions of RNA binding proteins. Science 265:615–621.
5. Burd, C. G., and G. Dreyfuss. 1994. RNA binding specificity of hnRNP A1:
significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing.
EMBO J. 13:1197–1204.
6. Champlin, D. T., and J. T. Lis. 1994. Distribution of B52 within a chromo-
somal locus depends on the level of transcription. Mol. Biol. Cell 5:71–79.
7. Chang-Yeh, A., D. E. Mold, and R. C. C. Huang. 1991. Identification of a
novel murine IAP-promoted placenta-expressed gene. Nucleic Acids Res.
19:3667–3672.
8. Christy, R. J., and R. C. C. Huang. 1988. Functional analysis of the long
terminal repeats of intracisternal A-particle genes: sequences within the U3
region determine both the efficiency and direction of promoter activity. Mol.
Cell. Biol. 8:1093–1102.
9. DeAngelo, D. J., J. Defalco, L. Rybacki, and G. Childs. 1995. The embryonic
enhancer-binding protein SSAP contains a novel DNA-binding domain
which has homology to several RNA-binding proteins. Mol. Cell. Biol. 15:
1254–1264.
10. Dong, B., D. S. Horowitz, R. Kobayashi, and A. R. Krainer. 1993. Purification
and cDNA cloning of HeLa cell p54nrb, a nuclear protein with two RNA
recognition motifs and extensive homology to human splicing factor PSF and
Drosophila NonA/Bj6. Nucleic Acids Res. 21:4085–4092.
11. Ellis, L., E. Clauser, D. O. Morgan, M. Edery, R. A. Roth, and W. J. Rutter.
1986. Replacement of insulin receptor tyrosine residues 1162 and 1163
compromises insulin-stimulated kinase activity and uptake of 2-deoxyglu-
cose. Cell 45:721–732.
12. Engelbrecht, J., S. Knudsen, and S. Brunak. 1992. G1C-rich tract in 59 end
of human introns. J. Mol. Biol. 227:108–113.
13. Falzon, M., and E. L. Kuff. 1989. Isolation and characterization of a protein
fraction that binds to enhancer core sequences in intracisternal A-particle
long terminal repeats. J. Biol. Chem. 264:21915–21922.
14. Falzon, M., and E. L. Kuff. 1991. Binding of the transcription factor EBP-80
mediates the methylation response of an intracisternal A-particle long ter-
minal repeat promoter. Mol. Cell. Biol. 11:117–125.
15. Gozani, O., J. G. Patton, and R. Reed. 1994. A novel set of spliceosome-
associated proteins and the essential splicing factor PSF bind stably to
pre-mRNAa prior to catalytic step II of the splicing reaction. EMBO J.
13:3356–3367.
16. Hager, D. A., and R. R. Burgess. 1980. Elution of proteins from sodium
dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and
renaturation of enzymatic activity: results with sigma subunit of Escherichia
coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes.
Anal. Biochem. 109:76–86.
17. Hallier, M., A. Tavitian, and F. Moreau-Gachelin. 1996. The transcription
factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein
p54nrb. J. Biol. Chem. 271:11171–11181.
18. Howe, C. C., and G. C. Overton. 1986. Expression of an intracisternal A
particle is elevated during differentiation of embryonal carcinoma cells. Mol.
Cell. Biol. 6:150–157.
19. Kamat, J. P., A. Basu, K. Satyamoorthy, L. Showe, and C. C. Howe. 1995.
IPEB transcription factor regulating the intracisternal A particle gene during
F9 cell differentiation is expressed at sites of lymphoid development. Mol.
Reprod. Dev. 41:8–15.
20. Krainer, A. R., T. Maniatis, B. Ruskin, and M. R. Green. 1984. Normal and
mutant human b-globin pre-mRNAs are accurately and efficiently spliced in
vitro. Cell 36:993–1005.
21. Kuff, E. L. 1990. Intracisternal particle in mouse neoplasia. Cancer Cells
2:398–400.
22. Kuff, E. L., and K. K. Lueders. 1988. The intracisternal A particle gene
family: structural and functional aspects. Adv. Cancer Res. 51:183–276.
23. Lamb, B. T., K. Satyamoorthy, L. Li, D. Solter, and C. C. Howe. 1991. CpG
methylation of an endogenous retroviral enhancer inhibits transcription fac-
tor binding and activity. Gene Expression 1:185–196.
24. Lamb, B. T., K. Satyamoorthy, D. Solter, A. Basu, M. Q. Xu, R. Weinmann,
and C. C. Howe. 1992. A DNA element that regulates expression of an
endogenous retrovirus during F9 cell differentiation is E1A dependent. Mol.
Cell. Biol. 12:4824–4833.
25. Leslie, K. B., F. Lee, and J. W. Schrader. 1991. Intracisternal A-type particle-
mediated activations of cytokine genes in a murine myelomonocytic leuke-
mia: generation of functional cytokine mRNAs by retroviral splicing events.
Mol. Cell. Biol. 11:5562–5570.
26. Lueders, K. K., J. W. Fewell, E. L. Kuff, and T. Koch. 1984. The long
terminal repeat of an endogenous intracisternal A-particle gene functions as
a promoter when introduced into eukaryotic cells by transfection. Mol. Cell.
Biol. 4:2128–2135.
27. Meitz, J. A., J. W. Fewell, and E. L. Kuff. 1992. Selective activation of a
discrete family of endogenous proviral elements in normal BALB/c lympho-
cytes. Mol. Cell. Biol. 12:220–228.
28. Nussinov, R. 1989. Conserved signals around the 59 splice sites in eukaryotic
nuclear precursor mRNAs: G-runs the frequent in the introns and C- in the
exons near both 59 and 39 splice sites. J. Biomol. Struct. Dyn. 6:985–1000.
29. O’Keefe, R. T., A. Mayeda, C. L. Sadowski, and A. R. Krainer. 1994. Dis-
ruption of pre-mRNA splicing in vivo results in reorganization of splicing
factors. J. Cell Biol. 124:249–260.
30. Patton, J. G., E. B. Porro, J. Galceran, P. Tempst, and B. Nadal-Ginard.
1993. Cloning and characterization of PSF, a novel pre-mRNA splicing
factor. Genes Dev. 7:393–406.
31. Sadowski, I., and M. Ptashne. 1989. A vector expressing Gal4(1-147) fusion
in mammalian cells. Nucleic Acids Res. 17:7539.
32. Satyamoorthy, K., K. Park, M. L. Atchison, and C. C. Howe. 1993. The
intracisternal A-particle upstream element interacts with transcription factor
YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA
promoter elements. Mol. Cell. Biol. 13:6621–6628.
33. Schindelin, H., M. A. Marahiel, and U. Heinemann. 1993. Universal nucleic
acid-binding domain revealed by crystal structure of the B. subtilis major
cold-shock protein. Nature (London) 364:164–168.
34. Sirand-Pugnet, P., P. Durosay, E. Brody, and J. Marie. 1995. An intronic
(A/U)GGG repeat enhances the splicing of an alternative intron of the
chicken beta-tropomyosin pre-mRNA. Nucleic Acids Res. 23:3501–3507.
35. Spector, D. L. 1993. Macromolecular domains within the cell nucleus. Annu.
Rev. Cell Biol. 9:265–315.
36. Tsai, D. E., D. S. Harper, and J. D. Keene. 1991. U1-snRNP-A protein
selects a ten nucleotide consensus sequence from a degenerate RNA pool
presented in various structural contexts. Nucleic Acids Res. 19:4931–4936.
37. Xing, Y., C. V. Johnson, P. R. Dobner, and J. B. Lawrence. 1993. Higher level
organization of individual gene transcription and RNA splicing. Science
259:1326–1330.
38. Yang, Y-S., J. H. Hanke, L. Carayannopoulos, C. M. Craft, J. D. Capra, and
P. W. Tucker. 1993. NonO, a non-POU-domain-containing, octamer-binding
protein, is the mammalian homolog of Drosophila nonAdiss. Mol. Cell. Biol.
13:5593–5603.
39. Zhang, G., K. L. Taneja, R. H. Singer, and M. R. Green. 1994. Localization
of pre-mRNA splicing in mammalian nuclei. Nature (London) 372:809–812.
40. Zierler, M., R. J. Christy, and R. C. C. Huang. 1992. Nuclear protein binding
to the 59 enhancer region of the intracisternal A particle long terminal
repeat. J. Biol. Chem. 267:21200–21206.
686 BASU ET AL. MOL. CELL. BIOL.
 o
n
 M
arch 11, 2014 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
